Changzhou Qianhong Biopharma Co Ltd
Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addit… Read more
Changzhou Qianhong Biopharma Co Ltd (002550) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.057x
Based on the latest financial reports, Changzhou Qianhong Biopharma Co Ltd (002550) has a cash flow conversion efficiency ratio of 0.057x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥156.34 Million) by net assets (CN¥2.76 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Changzhou Qianhong Biopharma Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Changzhou Qianhong Biopharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Changzhou Qianhong Biopharma Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Changzhou Qianhong Biopharma Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blacksky Technology Inc
NYSE:BKSY
|
-0.428x |
|
Laobaixing Pharmacy
SHG:603883
|
0.075x |
|
Cellcom Israel Ltd
PINK:CELJF
|
0.033x |
|
Beijing Hualian Hypermarket Co Ltd
SHG:600361
|
0.029x |
|
TSEC Corp
TW:6443
|
0.010x |
|
Sunway Construction Group Bhd
KLSE:5263
|
0.546x |
|
Guangzhou SiE Consulting Co Ltd
SHE:300687
|
0.006x |
|
Lakshmi Machine Works Limited
NSE:LAXMIMACH
|
0.017x |
Annual Cash Flow Conversion Efficiency for Changzhou Qianhong Biopharma Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.52 Billion | CN¥514.71 Million | 0.205x | -5.13% |
| 2023-12-31 | CN¥2.47 Billion | CN¥533.33 Million | 0.216x | +833.97% |
| 2022-12-31 | CN¥2.43 Billion | CN¥-71.47 Million | -0.029x | -160.08% |
| 2021-12-31 | CN¥2.12 Billion | CN¥103.56 Million | 0.049x | -68.17% |
| 2020-12-31 | CN¥2.07 Billion | CN¥317.28 Million | 0.154x | +121.81% |
| 2019-12-31 | CN¥2.33 Billion | CN¥161.55 Million | 0.069x | +590.82% |
| 2018-12-31 | CN¥2.54 Billion | CN¥25.45 Million | 0.010x | -72.22% |
| 2017-12-31 | CN¥2.45 Billion | CN¥88.52 Million | 0.036x | -60.41% |
| 2016-12-31 | CN¥2.42 Billion | CN¥221.01 Million | 0.091x | -27.00% |
| 2015-12-31 | CN¥2.29 Billion | CN¥286.50 Million | 0.125x | +5.67% |
| 2014-12-31 | CN¥2.13 Billion | CN¥252.01 Million | 0.118x | +45.10% |
| 2013-12-31 | CN¥1.97 Billion | CN¥160.47 Million | 0.081x | -23.84% |
| 2012-12-31 | CN¥1.87 Billion | CN¥199.82 Million | 0.107x | +28.62% |
| 2011-12-31 | CN¥1.77 Billion | CN¥146.82 Million | 0.083x | -79.94% |
| 2010-12-31 | CN¥413.78 Million | CN¥171.51 Million | 0.415x | +1109.63% |
| 2009-12-31 | CN¥243.68 Million | CN¥8.35 Million | 0.034x | -86.26% |
| 2008-12-31 | CN¥217.99 Million | CN¥54.36 Million | 0.249x | +46.60% |
| 2007-12-31 | CN¥211.61 Million | CN¥35.99 Million | 0.170x | -- |